Cannon Global Investment Management LLC Acquires Shares of 3,000 Natera, Inc. (NASDAQ:NTRA)

Cannon Global Investment Management LLC purchased a new position in Natera, Inc. (NASDAQ:NTRA - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 3,000 shares of the medical research company's stock, valued at approximately $475,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Blue Trust Inc. lifted its position in shares of Natera by 104.3% in the fourth quarter. Blue Trust Inc. now owns 190 shares of the medical research company's stock valued at $30,000 after acquiring an additional 97 shares in the last quarter. Versant Capital Management Inc lifted its holdings in Natera by 345.8% in the 4th quarter. Versant Capital Management Inc now owns 214 shares of the medical research company's stock valued at $34,000 after purchasing an additional 166 shares in the last quarter. EverSource Wealth Advisors LLC boosted its stake in Natera by 372.9% during the 4th quarter. EverSource Wealth Advisors LLC now owns 331 shares of the medical research company's stock worth $52,000 after purchasing an additional 261 shares during the last quarter. Principal Securities Inc. grew its holdings in shares of Natera by 20.7% during the fourth quarter. Principal Securities Inc. now owns 344 shares of the medical research company's stock worth $54,000 after buying an additional 59 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC raised its position in shares of Natera by 1,328.0% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 357 shares of the medical research company's stock valued at $57,000 after buying an additional 332 shares during the last quarter. Hedge funds and other institutional investors own 99.90% of the company's stock.

Remove Ads

Analysts Set New Price Targets

NTRA has been the topic of a number of recent research reports. JPMorgan Chase & Co. boosted their price target on shares of Natera from $160.00 to $200.00 and gave the stock an "overweight" rating in a research report on Friday, December 13th. Barclays began coverage on Natera in a research report on Thursday, January 23rd. They issued an "overweight" rating and a $200.00 price target for the company. StockNews.com upgraded Natera from a "sell" rating to a "hold" rating in a research report on Wednesday, March 19th. Piper Sandler upped their target price on Natera from $200.00 to $205.00 and gave the company an "overweight" rating in a report on Tuesday, March 4th. Finally, BTIG Research reiterated a "buy" rating on shares of Natera in a report on Friday, February 28th. One analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, Natera has a consensus rating of "Moderate Buy" and a consensus price target of $178.12.

Insiders Place Their Bets

In related news, CEO Steven Leonard Chapman sold 6,702 shares of Natera stock in a transaction on Monday, March 17th. The stock was sold at an average price of $146.03, for a total value of $978,693.06. Following the completion of the transaction, the chief executive officer now directly owns 203,354 shares in the company, valued at approximately $29,695,784.62. This trade represents a 3.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Gail Boxer Marcus sold 4,000 shares of Natera stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $147.69, for a total transaction of $590,760.00. Following the completion of the transaction, the director now owns 9,704 shares of the company's stock, valued at $1,433,183.76. This represents a 29.19 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 306,797 shares of company stock worth $48,940,883 over the last three months. Company insiders own 7.60% of the company's stock.

Natera Trading Down 2.9 %

Natera stock traded down $4.36 during trading on Friday, hitting $143.94. The company had a trading volume of 1,258,459 shares, compared to its average volume of 1,364,577. The stock has a market cap of $19.46 billion, a price-to-earnings ratio of -81.78 and a beta of 1.80. The company has a current ratio of 4.39, a quick ratio of 4.23 and a debt-to-equity ratio of 0.33. Natera, Inc. has a 1-year low of $83.13 and a 1-year high of $183.00. The company's 50 day simple moving average is $159.60 and its 200-day simple moving average is $150.72.

Natera (NASDAQ:NTRA - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The medical research company reported ($0.41) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.42) by $0.01. Natera had a negative return on equity of 26.23% and a negative net margin of 14.01%. The firm had revenue of $476.10 million for the quarter, compared to the consensus estimate of $447.91 million. As a group, analysts expect that Natera, Inc. will post -1.49 EPS for the current fiscal year.

Natera Profile

Natera, Inc, a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born.